Literature DB >> 21321934

Multipotent progenitor cells derived from adult peripheral blood of swine have high neurogenic potential in vitro.

Nadja Spitzer1, Gregory S Sammons, Heather M Butts, Lawrence M Grover, Elmer M Price.   

Abstract

Peripheral blood-derived multipotent adult progenitor cells (PBD-MAPCs) are a novel population of stem cells, isolated from venous blood of green fluorescent protein transgenic swine, which proliferate as multicellular non-adherent spheroids. Using a simple differentiation protocol, a large proportion of these cells developed one of five distinct neural cell phenotypes, indicating that these primordial cells have high neurogenic potential. Cells exhibiting neural morphologies developed within 48 h of exposure to differentiation conditions, increased in percentage over 2 weeks, and stably maintained the neural phenotype for three additional weeks in the absence of neurogenic signaling molecules. Cells exhibited dynamic neural-like behaviors including extension and retraction of processes with growth cone-like structures rich in filamentous actin, cell migration following a leading process, and various cell-cell interactions. Differentiated cells expressed neural markers, NeuN, β-tubulin III and synaptic proteins, and progenitor cells expressed the stem cell markers nestin and NANOG. Neurally differentiated PBD-MAPCs exhibited voltage-dependent inward and outward currents and expressed voltage-gated sodium and potassium channels, suggestive of neural-like membrane properties. PBD-MAPCs expressed early neural markers and developed neural phenotypes when provided with an extracellular matrix of laminin without the addition of cytokines or growth factors, suggesting that these multipotent cells may be primed for neural differentiation. PBD-MAPCs provide a model for understanding the mechanisms of neural differentiation from non-neural sources of adult stem cells. A similar population of cells, from humans or xenogeneic sources, may offer the potential of an accessible, renewable and non-tumorigenic source of stem cells for treating neural disorders.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21321934      PMCID: PMC3160519          DOI: 10.1002/jcp.22670

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  63 in total

1.  Multipotent adult progenitor cell lines originating from the peripheral blood of green fluorescent protein transgenic swine.

Authors:  Elmer M Price; Randall S Prather; C Michael Foley
Journal:  Stem Cells Dev       Date:  2006-08       Impact factor: 3.272

Review 2.  Therapeutic potential of adult stem cells.

Authors:  Nedime Serakinci; W Nicol Keith
Journal:  Eur J Cancer       Date:  2006-05-05       Impact factor: 9.162

Review 3.  The promise of stem cells for neural repair.

Authors:  Robert H Miller
Journal:  Brain Res       Date:  2006-03-23       Impact factor: 3.252

4.  Skin-derived stem cells transplanted into resorbable guides provide functional nerve regeneration after sciatic nerve resection.

Authors:  C Marchesi; M Pluderi; F Colleoni; M Belicchi; M Meregalli; A Farini; D Parolini; L Draghi; M E Fruguglietti; M Gavina; L Porretti; A Cattaneo; M Battistelli; A Prelle; M Moggio; S Borsa; L Bello; D Spagnoli; S M Gaini; M C Tanzi; N Bresolin; N Grimoldi; Y Torrente
Journal:  Glia       Date:  2007-03       Impact factor: 7.452

5.  Comparison of neuron-like cells derived from bone marrow stem cells to those differentiated from adult brain neural stem cells.

Authors:  Shijie Song; Shuojing Song; Hongling Zhang; Javier Cuevas; Juan Sanchez-Ramos
Journal:  Stem Cells Dev       Date:  2007-10       Impact factor: 3.272

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Specification of a dopaminergic phenotype from adult human mesenchymal stem cells.

Authors:  Katarzyna A Trzaska; Eldo V Kuzhikandathil; Pranela Rameshwar
Journal:  Stem Cells       Date:  2007-07-26       Impact factor: 6.277

Review 9.  Human stem cells for CNS repair.

Authors:  Rike Zietlow; Emma L Lane; Stephen B Dunnett; Anne E Rosser
Journal:  Cell Tissue Res       Date:  2007-09-28       Impact factor: 5.249

10.  Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo.

Authors:  Lucy Anderson; Rowan M Burnstein; Xiaoling He; Richard Luce; Rob Furlong; Tom Foltynie; Peter Sykacek; David K Menon; Maeve A Caldwell
Journal:  Exp Neurol       Date:  2007-01-17       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.